Literature DB >> 9286474

Management of viral hepatitis: clinical and public health perspectives--a consensus statement. CASL Hepatitis Consensus Group. Canadian Association for Study of the Liver.

M Sherman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9286474     DOI： 10.1155/1997/454278

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN： 0835-7900            Impact factor:   3.522


× No keyword cloud information.
  9 in total

Review 1.  Hepatitis C: medical information update. Canadian Liver Foundation. National Hepatitis C Education Program.

Authors: 
Journal:  Can J Public Health       Date:  2000 Jul-Aug

2.  Hepatitis.

Authors:  M Krajden
Journal:  Can J Infect Dis       Date:  2001-11

Review 3.  Less hype, more hope.

Authors:  E Shaffer
Journal:  CMAJ       Date:  1997-12-15       Impact factor: 8.262

Review 4.  Hepatitis infection in the treatment of opioid dependence and abuse.

Authors:  Thomas F Kresina; Diana Sylvestre; Leonard Seeff; Alain H Litwin; Kenneth Hoffman; Robert Lubran; H Westley Clark
Journal:  Subst Abuse       Date:  2008-04-28

5.  Feasibility and outcome of HCV treatment in a Canadian federal prison population.

Authors:  John Farley; Shawn Vasdev; Benedikt Fischer; Emma Haydon; Jürgen Rehm; Theresa A Farley
Journal:  Am J Public Health       Date:  2005-08-30       Impact factor: 9.308

Review 6.  Hepatitis C among drug users: consensus guidelines on management in general practice.

Authors:  J Barry; M Bourke; M Buckley; B Coughlan; D Crowley; W Cullen; S Dooley; S Keating; D Kelleher; J Moloney; F Murray; P A McCormick; P MacMathuna; J O'Connor; J O'Grady; C O'Sullivan; P O'Sullivan; C Quinn; B Smyth; B Sweeney
Journal:  Ir J Med Sci       Date:  2004 Jul-Sep       Impact factor: 1.568

7.  The management of chronic viral hepatitis: A Canadian consensus conference 2004.

Authors:  Morris Sherman; Vincent Bain; Jean-Pierre Villeneuve; Robert P Myers; Curtis Cooper; Steven Martin; Catherine Lowe
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-11       Impact factor: 2.471

8.  Predictors of antiviral therapy in a post-transfusion cohort of hepatitis C patients.

Authors:  Maciej Witkos; Qi-Long Yi; Jenny Heathcote; Moira K Kapral; Murray D Krahn
Journal:  Can J Gastroenterol       Date:  2006-02       Impact factor: 3.522

9.  Treatment outcomes in a centralized specialty clinic for hepatitis C virus are comparable with those from clinical trials.

Authors:  Kelly De Kaita; Stephen Wong; Eberhard Renner; Gerald Y Minuk
Journal:  Can J Gastroenterol       Date:  2006-02       Impact factor: 3.522
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.